DUBLIN, Ohio — Cardinal Health announced Wednesday that it has extended its agreements with CVS Health to distribute pharmaceuticals to retail pharmacies and distribution centers through June 30, 2027.
“We value our long-standing partnership with CVS Health, and we are honored to continue our important work together to bring our best-in-class abilities together for their customers,” stated Mike Kaufmann, CEO of Cardinal Health.
The company reaffirms its fiscal year 2022 guidance range for non-GAAP diluted earnings per share attributable to Cardinal Health, Inc. of $5.60 to $5.90.
The post Cardinal extends distribution agreements with CVS appeared first on CDR – Chain Drug Review.